ID   LB-832
AC   CVCL_E904
DR   Wikidata; Q54902017
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3927997;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~48 hours (PubMed=3927997).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E903 ! LB-831
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=3927997; DOI=10.1182/blood.V66.3.548.548;
RA   Durie B.G.M., Vela E.E., Baum V., Leibovitz A., Payne C.M.,
RA   Richter L.C., Grogan T.M., Trent J.M.;
RT   "Establishment of two new myeloma cell lines from bilateral pleural
RT   effusions: evidence for sequential in vivo clonal change.";
RL   Blood 66:548-555(1985).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//